Evidence map›Paper›PMID 32983097›Full record

ArticleFrontiers in immunology2020

A Systematic, Unbiased Mapping of CD8

Anette Stryhn, Michael Kongsgaard, Michael Rasmussen, Mikkel Nors Harndahl, Thomas Østerbye, Maria Rosaria Bassi, Søren Thybo, Mette Gabriel, Morten Bagge Hansen, Morten Nielsen and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Anette StryhnDepartment of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Michael KongsgaardDepartment of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Michael RasmussenDepartment of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Mikkel Nors HarndahlDepartment of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Thomas ØsterbyeDepartment of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Maria Rosaria BassiDepartment of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Søren ThyboDepartment of Infectious Diseases, Copenhagen University Hospital, Copenhagen, Denmark.
Mette GabrielMedical Office, Copenhagen, Denmark.
Morten Bagge HansenDepartment of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
Morten NielsenDepartment of Health Technology, The Technical University of Denmark, Lyngby, Denmark.
Jan Pravsgaard ChristensenDepartment of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Allan Randrup ThomsenDepartment of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Soren BuusDepartment of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
University of Copenhagen · DKCopenhagen University Hospital · DKTechnical University of Denmark · DK

Funding

NIAID NIH HHS HHSN272200900045C
6 · The paper itself

Abstract

Examining CD8

Indexed as

VaccinationBetacoronavirusCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCohort StudiesCoronavirus InfectionsCOVID-19Epitopes, T-LymphocyteHealthy VolunteersHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHumansImmunogenicity, VaccinePandemicsPneumonia, ViralSARS-CoV-2Epitopes, T-LymphocyteHistocompatibility Antigens Class IHistocompatibility Antigens Class IIYellow Fever VaccineCD4+ and CD8+ T cell epitope discoveryforward-reverse immunologyimmunodominance and immunodominationimmunogenicitypeptide-MHC predictorspeptide-MHC tetramersyellow fever vaccination

Identifiers

PMID32983097
PMCPMC7489334
OpenAlexW3082538375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.